[1]SIEGEL RL,GIAQUINTO AN,JEMAL A.Cancer statistics,2024[J].CA Cancer J Clin,2024,74(1):12-49.
[2] MURPHY CC,ZAKI TA.Changing epidemiology of colorectal cancer-birth cohort effects and emerging risk factors[J].Nat Rev Gastroenterol Hepatol,2024,21(1):25-34.
[3] SHIN AE,GIANCOTTI FG,RUSTGI AK.Metastatic colorectal cancer:mechanisms and emerging therapeutics[J].Trends Pharmacol Sci,2023,44(4):222-236.
[4] HARROLD E,KEANE F,WALCH H,et al.Molecular and clinical determinants of acquired resistance and treatment duration for targeted therapies in colorectal cancer[J].Clin Cancer Res,2024,30(12):2672-2683.
[5] WAN BS,CHENG M,ZHANG L.Insulin-like growth factor 2 mRNA-binding protein 1 promotes cell proliferation via activation of AKT and is directly targeted by microRNA-494 in pancreatic cancer[J].World J Gastroenterol,2019,25(40):6063-6076.
[6] XIE S,XIA L,SONG Y,et al.Insights into the biological role of NEDD4L E3 ubiquitin ligase in human cancers[J].Front Oncol,2021,11:774648.
[7] GOEL P,MANNING JA,KUMAR S.NEDD4-2(NEDD4L):the ubiquitin ligase for multiple membrane proteins[J].Gene,2015,557(1):1-10.
[8] TANKSLEY JP,CHEN X,COFFEY RJ.NEDD4L is downregulated in colorectal cancer and inhibits canonical WNT signaling[J].PLoS One,2013,8(11):e81514.
[9] YAO B,ZHANG Q,YANG Z,et al.CircEZH2/miR-133b/IGF2BP2 aggravates colorectal cancer progression via enhancing the stability of m(6)A-modified CREB1 mRNA[J].Mol Cancer,2022,21(1):140.
[10] HELLWINKEL OJ,ASONG LE,ROGMANN JP,et al.Transcription alterations of members of the ubiquitin-proteasome network in prostate carcinoma[J].Prostate Cancer Prostatic Dis,2011,14(1):38-45.
[11] ROTIN D,PRAG G.Physiological functions of the ubiquitin ligases NEDD4-1 and NEDD4-2[J].Physiology(Bethesda),2024,39(1):18-29.
[12] SAKASHITA H,INOUE H,AKAMINE S,et al.Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer[J].Ann Surg Oncol,2013,20(Suppl 3):S590-598.
[13] TAKEUCHI T,ADACHI Y,NAGAYAMA T,et al.NEDD4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer[J].Int J Exp Pathol,2011,92(2):79-86.
[14] GAO C,PANG L,REN C,et al.Decreased expression of NEDD4L correlates with poor prognosis in gastric cancer patient[J].Med Oncol,2012,29(3):1733-1738.
[15] DING Y,ZHANG Y,XU C,et al.HECT domain-containing E3 ubiquitin ligase NEDD4L negatively regulates Wnt signaling by targeting dishevelled for proteasomal degradation[J].J Biol Chem,2013,288(12):8289-8298.
[16] YANG H,ZHU J,WANG G,et al.STK35 is ubiquitinated by NEDD4L and promotes glycolysis and inhibits apoptosis through regulating the AKT signaling pathway,influencing chemoresistance of colorectal cancer[J].Front Cell Dev Biol,2020,8:582695.
[17] SUPIOT S,GOURAUD W,CAMPION L,et al.Early dynamic transcriptomic changes during preoperative radiotherapy in patients with rectal cancer:a feasibility study[J].World J Gastroenterol,2013,19(21):3249-3254.
[18] KWON YT,CIECHANOVER A.The ubiquitin code in the ubiquitin-proteasome system and autophagy[J].Trends Biochem Sci,2017,42(11):873-886.
[19] YOSHIDA Y,TANAKA K.Cytosolic N-glycans:Triggers for ubiquitination directing proteasomal and autophagic degradation:Molecular systems for monitoring cytosolic N-glycans as signals for unwanted proteins and organelles[J/OL].Bioessays,2018,40(3)[2023-06-10].https://pubmed.ncbi.nlm.nih.gov/29436721/.doi:10.1002/bies.
[20] 陆欣苑,冯延璐,葛毅凌,等.m6A结合蛋白IGF2BP2的遗传变异与胃癌发病风险的关联[J].现代肿瘤医学,2023,31(21):3973-3979.
LU XY,FENG YL,GE YL,et al.Association between genetic variants of m6A binding protein IGF2BP2 with the risk of gastric cancer[J].Modern Oncology,2023,31(21):3973-3979.
[21] CUI J,TIAN J,WANG W,et al.IGF2BP2 promotes the progression of colorectal cancer through a YAP-dependent mechanism[J].Cancer Sci,2021,112(10):4087-4099.
[22] XU S,ZHANG H,CHONG Y,et al.YAP promotes VEGFA expression and tumor angiogenesis though Gli2 in human renal cell carcinoma[J].Arch Med Res,2019,50(4):225-233.
[23] HAN N,TIAN W,YU N,et al.YAP1 is required for the angiogenesis in retinal microvascular endothelial cells via the inhibition of MALAT1-mediated miR-200b-3p in high glucose-induced diabetic retinopathy[J].J Cell Physiol,2020,235(2):1309-1320.
[24] ZHANG C,BIAN M,CHEN X,et al.Oroxylin a prevents angiogenesis of LSECs in liver fibrosis via inhibition of YAP/HIF-1alpha signaling[J].J Cell Biochem,2018,119(2):2258-2268.
[25] LI Y,ZHAO L,ZHANG H,et al.Extracellular matrix stiffness controls VEGF165 secretion and neuroblastoma angiogenesis via the YAP/RUNX2/SRSF1 axis[J].Angiogenesis,2022,25(1):13-14.